Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
16.90
-0.06 (-0.35%)
At close: Sep 18, 2026, 4:00 PM EDT
16.96
+0.06 (0.36%)
After-hours: Sep 18, 2026, 7:43 PM EDT
Aurinia Pharmaceuticals Market Cap
Aurinia Pharmaceuticals has a market cap or net worth of $2.25 billion as of September 18, 2026. Its market cap has increased by 38.89% in one year.
Market Cap
2.25B
Enterprise Value
1.87B
1-Year Change
38.89%
Ranking
Category
Stock Price
$16.90
ChartMarket Cap Chart
Since September 3, 2014, Aurinia Pharmaceuticals's market cap has increased from $125.50M to $2.25B, an increase of 1,691.69%. That is a compound annual growth rate of 27.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 2.25B | 6.93% |
| Dec 31, 2025 | 2.10B | 63.56% |
| Dec 31, 2024 | 1.29B | -0.41% |
| Dec 29, 2023 | 1.29B | 110.29% |
| Dec 30, 2022 | 613.90M | -79.30% |
| Dec 31, 2021 | 2.97B | 69.58% |
| Dec 31, 2020 | 1.75B | -8.45% |
| Dec 31, 2019 | 1.91B | 233.25% |
| Dec 31, 2018 | 573.20M | 50.68% |
| Dec 29, 2017 | 380.40M | 366.75% |
| Dec 30, 2016 | 81.50M | 3.69% |
| Dec 31, 2015 | 78.60M | -31.17% |
| Dec 31, 2014 | 114.20M | -9.00% |
| Sep 3, 2014 | 125.50M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nektar Therapeutics | 2.33B |
| SELLAS Life Sciences Group | 2.33B |
| Ocular Therapeutix | 2.23B |
| Palvella Therapeutics | 2.22B |
| Generate Biomedicines | 2.20B |
| Sarepta Therapeutics | 2.18B |
| Trevi Therapeutics | 2.17B |
| UroGen Pharma | 2.15B |